Merck bets on flu prevention with $9.2 billion deal for Cidara Therapeutics
Merck will acquire Cidara Therapeutics in a nearly $9.2 billion deal, gaining access to an experimental flu drug in its effort to diversify ahead of patent loss for its
November 14, 2025
South Korean minister vows to expand legal remedies for adoptees and other rights victims
Zelenskyy says Ukrainian forces shot down Shahed drones in Middle Eastern countries during Iran war
US and Iran prepare for ceasefire talks as Netanyahu authorizes negotiations with Lebanon
Gaza marks 6 months of a ceasefire that may offer lessons for the Iran war
A country-by-country glance at Pope Leo XIV's trip to Africa
Pope's Africa trip takes him to a source of growth for the church, and critical challenges
Islanders' Matthew Schaefer ties Brian Leetch's NHL record for goals by a rookie defenseman